Holds one active US DMF for neostigmine, filing since 2015. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 3 markets.
Holds one active US DMF for neostigmine, filing since 2015. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 3 markets.
Holds one active US DMF for neostigmine, filing since 2017. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds one active US DMF for neostigmine, filing since 2015. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 26 markets.
Holds one active US DMF for neostigmine, filing since 2018. Its 2025 FDA inspection closed as VAI.
Holds 2 active US DMFs for neostigmine, filing since 2018. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
This page filters the worldwide Neostigmine manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for neostigmine and what filings they hold.
Chat with Fred, your AI analyst